Tohoku University · Institute for Medical Innovation

Research keywordsnon-small cell lung cancer・lung cancer immunotherapy・COVID-19 vaccination・atezolizumab combination therapy・eosinophil homeostasis・BCG vaccination・bronchial asthma・vocal cord dysfunction

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials.Hiromi Matsumoto, Nobuyuki Horita, Kentaro Ito, Risa Ebina-Shibuya, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko
• Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.Alexandra Dreyzin, Anne Marijn Kramer, Bonnie Yates, Hao-Wei Wang, Bita Sahaf, Constance Yuan, Dorota Klysz, Ramya Tunuguntla, Zachary Ehlinger, Skyler Reitberg, Serifat Adebola, Angela Su, Risa Ebina-Shibuya, Dongya Jia, Sooraj Achar, Sunita Patil, Kathryn Martin, Nikeshan Jeyakumar, Kara L Davis, Terry Fry, Crystal L Mackall, Naomi Taylor, Gregoire Altan-Bonnet, Steven Highfill, Steven Feldman, David F Stroncek, Christopher Chien, Liora Michal Schultz, Matthew J Frank, Lori S Muffly, Haneen Shalabi, Sneha Ramakrishna, Nirali N Shah
• Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemia.Hiroki Kato, Ari Itoh-Nakadai, Mitsuyo Matsumoto, Yusho Ishii, Miki Watanabe-Matsui, Masatoshi Ikeda, Risa Ebina-Shibuya, Yuki Sato, Masahiro Kobayashi, Hironari Nishizawa, Katsushi Suzuki, Akihiko Muto, Tohru Fujiwara, Yasuhito Nannya, Luca Malcovati, Mario Cazzola, Seishi Ogawa, Hideo Harigae, Kazuhiko Igarashi
• TSLP-targeting therapy: Beyond allergy?Risa Ebina-Shibuya, Warren J Leonard

• 非小細胞肺癌におけるtRNA修飾に着目した翻訳機構の解明と新規治療法の開発2025 · 2025年1月 ～ 2026年12月
• 非小細胞肺癌の病態における翻訳機構の解明とtRNA修飾に着目した新規治療法の開発2024 · 2024年12月 ～ 2026年11月
• 肺がん微小環境のTSLPシグナルを標的としたCAR-T療法の開発提供機関： Kobayashi Foundation for Cancer Research
• メタボロミクスに基づくメタボローム改変CAR-T療法の肺癌への応用渋谷 里紗

• Official profile